RBABM MEDICAL LIMITED

Company Registration Number:
10723906 (England and Wales)

Unaudited abridged accounts for the year ended 30 April 2025

Period of accounts

Start date: 01 May 2024

End date: 30 April 2025

RBABM MEDICAL LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8

RBABM MEDICAL LIMITED

Company Information

for the Period Ended 30 April 2025




Director: Robert Howard Taylor
Registered office: 14
Saxon Place
Eastbourne
England
BN21 1TY
Company Registration Number: 10723906 (England and Wales)

RBABM MEDICAL LIMITED

Directors' Report Period Ended 30 April 2025

The directors present their report with the financial statements of the company for the period ended 30 April 2025

Principal Activities

Medical Services

Directors

The directors shown below have held office during the whole of the period from 01 May 2024 to 30 April 2025
Robert Howard Taylor

This report was approved by the board of directors on 10 September 2025
And Signed On Behalf Of The Board By:

Name: Robert Howard Taylor
Status: Director

RBABM MEDICAL LIMITED

Profit and Loss Account

for the Period Ended 30 April 2025


Notes

2025
£

2024
£
Gross Profit or (Loss) 82,336 86,730
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 0 ) ( 0 )
Administrative Expenses ( 50,374 ) ( 50,760 )
Operating Profit or (Loss) 31,962 35,970
Interest Receivable and Similar Income 0 0
Interest Payable and Similar Charges ( 0 ) ( 0 )
Profit or (Loss) Before Tax 31,962 35,970
Tax on Profit ( 6,073 ) ( 6,834 )
Profit or (Loss) for Period 25,889 29,136

The notes form part of these financial statements

RBABM MEDICAL LIMITED

Balance sheet

As at 30 April 2025


Notes

2025
£

2024
£
Fixed assets
Total fixed assets: - -
Current assets
Debtors: 3,668 2,090
Cash at bank and in hand: 3,764 7,708
Total current assets: 7,432 9,798
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 7,177 ) ( 8,632 )
Net current assets (liabilities): 255 1,166
Total assets less current liabilities: 255 1,166
Total net assets (liabilities): 255 1,166

The notes form part of these financial statements

RBABM MEDICAL LIMITED

Balance sheet continued

As at 30 April 2025


Notes

2025
£

2024
£
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 254 1,165
Shareholders funds: 255 1,166

For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 10 September 2025
And Signed On Behalf Of The Board By:

Name: Robert Howard Taylor
Status: Director

The notes form part of these financial statements

RBABM MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

RBABM MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2025

  • 2. Employees


    2025

    2024
    Average number of employees during the period 1 1

RBABM MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2025

  • 3. Off balance sheet disclosure

    No